Levamisole (Ergamisol)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 02:13, 28 April 2022 by Jwarner (talk | contribs)
Jump to navigation Jump to search

This agent is not commercially available in the United States and is included for historic purposes only.

Diseases for which it was used

History of changes in FDA indication

  • 6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer.

Also known as

  • Brand name: Ergamisol
Retrieved from "https://hemonc.org/w/index.php?title=Levamisole_(Ergamisol)&oldid=55865"